Cold & Cough Remedies - Western Africa

  • Western Africa
  • In Western Africa, the revenue generated in the Cold & Cough Remedies market market in 2024 amounts to US$0.36bn.
  • It is projected that the market will experience an annual growth rate of 12.20% (CAGR 2024-2029).
  • When compared to the global market, the in the United States generates the highest revenue with US$11,190.00m in 2024.
  • Taking into account the total population figures, in 2024, per person revenues of US$0.88 are generated.
  • The demand for cold and cough remedies in Western Africa has seen a significant increase due to the prevalence of respiratory infections and changing weather patterns.

Key regions: United States, Japan, Australia, United Kingdom, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies market in Western Africa is experiencing steady growth due to changing customer preferences, emerging trends, and local special circumstances. Customer preferences in Western Africa are shifting towards natural and herbal remedies for cold and cough. Consumers are becoming more health-conscious and are seeking products that are perceived to be safer and more effective. This preference for natural remedies is driven by the belief that they have fewer side effects and are more in line with traditional healing practices. As a result, there is a growing demand for herbal cold and cough remedies in the market.Trends in the market show that there is an increasing focus on product innovation and differentiation. Companies are introducing new formulations and packaging designs to attract customers. For example, some companies are offering cold and cough remedies in convenient single-dose sachets, making it easier for consumers to take the medication on the go. Additionally, there is a growing trend towards combination products that offer relief for multiple symptoms, such as congestion, sore throat, and cough. This allows customers to address multiple symptoms with a single product, which is convenient and cost-effective.Local special circumstances in Western Africa also contribute to the development of the Cold & Cough Remedies market. The region experiences a high prevalence of respiratory infections due to factors such as poor air quality, crowded living conditions, and limited access to healthcare. This creates a significant demand for cold and cough remedies as people seek relief from their symptoms. Furthermore, Western Africa has a large population of young children who are particularly vulnerable to respiratory infections. This drives the demand for pediatric cold and cough remedies that are specifically formulated for children.Underlying macroeconomic factors also play a role in the development of the market. Western Africa is experiencing economic growth, which is leading to an increase in disposable income. As people have more money to spend on healthcare products, they are more likely to invest in cold and cough remedies. Additionally, the region is witnessing rapid urbanization, which is driving the demand for over-the-counter medications. Urban dwellers have easier access to pharmacies and are more likely to seek medical treatment for their cold and cough symptoms.In conclusion, the Cold & Cough Remedies market in Western Africa is developing due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The shift towards natural and herbal remedies, product innovation, and the high prevalence of respiratory infections contribute to the growth of the market. As the region continues to experience economic growth and urbanization, the demand for cold and cough remedies is expected to further increase.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)